Evotec Se (EVO) Gross Profit Margin starting from the fourth quarter 2025 to fourth quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Evotec Se  (NASDAQ: EVO)


Evotec Se's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EVO Gross Profit Margin (Dec 31 2025)
Q4 		0
Q3 		0
Q2 		0
Q1 		(Dec 31 2024)
Q4
Y / Y Revenue Change -1.08 %
Seq. Revenue Change -
Revenue In Millions $882.98
Gross Profit Margin 14.49 %
Gross Profit Margin Total Ranking # 3399
Gross Profit In Millions $127.93
Y / Y Gross Profit Change -0.57 %
Seq. Gross Profit Change -


Commenting fourth quarter 2025 Gross Profit Margin



Observing fourth quarter 2025 results within Major Pharmaceutical Preparations industry 153 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 3399.
Learn about Gross Margin
EVO's Gross Profit Margin fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 154
Healthcare Sector # 465
Overall # 3378

Gross Profit Margin Statistics
High Average Low
24.52 % 19.8 % 14.41 %
(Dec 31 2021)   (Dec 31 2024)


EVO Gross Income Trends • More of EVO's Profitabilty Ratios • EVO Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
EVO's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
EVO's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for EVO's Competitors
Gross Profit Margin Profit Margin for Evotec Se's Suppliers
Gross Profit Margin Profit Margin for EVO's Customers

You may also want to know
EVO's Annual Growth Rates EVO's Profitability Ratios EVO's Asset Turnover Ratio EVO's Dividend Growth
EVO's Roe EVO's Valuation Ratios EVO's Financial Strength Ratios EVO's Gross Profit Growth
EVO's Roa EVO's Inventory Turnover Ratio EVO's Growth Rates EVO's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2025, within Major Pharmaceutical Preparations Industry Gross Profit MarginDec 31 2025 MRQ Gross ProfitDec 31 2025 MRQ Revenue
Hyperion Defi inc   38.89 %$ 0.193  Millions$ 0.496  Millions
Hutchmed china Limited  38.68 %$ 212.163  Millions$ 548.512  Millions
Grifols Sa  38.00 %$ 3,202.080  Millions$ 8,426.880  Millions
Kamada Ltd   37.98 %$ 16.967  Millions$ 44.678  Millions
Amneal Pharmaceuticals Inc   36.46 %$ 297.190  Millions$ 815.190  Millions
Lftd Partners Inc   35.64 %$ 2.999  Millions$ 8.415  Millions
Phibro Animal Health Corporation  35.50 %$ 132.656  Millions$ 373.656  Millions
Sunshine Biopharma Inc   35.31 %$ 3.029  Millions$ 8.577  Millions
Pmgc Holdings Inc   35.27 %$ 0.107  Millions$ 0.304  Millions
Perrigo Company Plc  32.64 %$ 362.200  Millions$ 1,109.600  Millions
Jaguar Health Inc   31.99 %$ 1.035  Millions$ 3.235  Millions
Prophase Labs Inc   31.51 %$ 0.247  Millions$ 0.784  Millions
Viatris Inc   30.99 %$ 1,147.900  Millions$ 3,703.600  Millions
Maravai Lifesciences Holdings Inc   25.64 %$ 12.842  Millions$ 50.088  Millions
Inmed Pharmaceuticals Inc  22.46 %$ 0.184  Millions$ 0.820  Millions
Siga Technologies Inc  21.20 %$ 0.804  Millions$ 3.794  Millions
Rockwell Medical inc   19.51 %$ 3.878  Millions$ 19.878  Millions
Bio Green Med Solution Inc   18.17 %$ 0.121  Millions$ 0.666  Millions
Evotec Se  14.49 %$ 127.928  Millions$ 882.978  Millions
China Pharma Holdings Inc  12.30 %$ 0.151  Millions$ 1.226  Millions
Intercure Ltd   12.28 %$ 33.181  Millions$ 270.200  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.